Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04MNL
|
|||
| Former ID |
DIB001137
|
|||
| Drug Name |
SERM-3339
|
|||
| Synonyms |
HMR-3339; SERM compound, Aventis; 3339
Click to Show/Hide
|
|||
| Indication | Osteoporosis [ICD-11: FB83.0; ICD-10: M85.8] | Discontinued in Phase 2 | [1] | |
| Company |
Hoechst Marion Roussel Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800013842) | |||
| REF 2 | CN patent application no. 102406650, Sex steroid precursors alone or in combination with selective estrogen receptor modulator for prevention and treatment of vaginal dryness and sexual dysfunction in postmenop. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.